Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity

Article ID	Journal	Published Year	Pages	File Type
8485844	Vaccine	2018	8 Pages	PDF

Abstract

ClinicalTrials.gov registration number: NCT01701999.

Keywords

CDC NAC MNA PBT BoNT CDPH MedDRA SAE Aes AUC TEAE United States botulism infant botulism Medical Dictionary for Regulatory Activities Intramuscular Adverse events Serious adverse event treatment-emergent adverse event area under the plasma concentration-time curve United States Centers for Disease Control and Prevention Botulinum neurotoxin California Department of Public Health

Related Topics

Life Sciences Immunology and Microbiology Immunology

Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity

Authors

Jessica M. Khouri, Ruth N. Motter, Stephen S. Arnon,